Keele Wurst, PhD

GSK
Cary, NC, United States

Keele Wurst is currently Head of Immunology and Emerging therapies in Epidemiology. She has been at GSK for almost 20 years, working across therapy areas in safety, pregnancy, pediatrics. She is trained in clinical pharmacy with a B.S. in Pharmacy from the University of Pittsburgh and a M.S in Pharmaceutical Policy / PhD in Pharmacoepidemiology from the University of North Carolina, Chapel Hill.

Presentation(s):

• 0154: Incidence and Prevalence of Connective Tissue Diseases with Interstitial Lung Disease (CTD-ILD) in the United States

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): GlaxoSmithKlein(GSK): Employee (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)